AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Gilead Sciences to Present at the Bank of America Merrill Lynch 2019 Health Care Conference on Tuesday, May 14

May 6, 2019

FOSTER CITY, Calif.--(BUSINESS WIRE)--May 6, 2019--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Robin L. Washington, Gilead’s Executive Vice President and Chief Financial Officer, and John McHutchison, AO, MD, Gilead’s Chief Scientific Officer and Head of Research & Development, will participate in a fireside chat at the Bank of America Merrill Lynch 2019 Health Care Conference in Las Vegas on Tuesday, May 14 at 10:00 a.m. Pacific Time.

The audio portion of the fireside chat will be accessible live through the company’s Investors page at http://investors.gilead.com/. Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be required to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com , follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190506005628/en/

CONTACT: Sung Lee

Investor Relations

(650) 524-7792

KEYWORD: UNITED STATES EUROPE NORTH AMERICA CALIFORNIA NEVADA

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS HOSPITALS PHARMACEUTICAL

SOURCE: Gilead Sciences, Inc.

Copyright Business Wire 2019.

PUB: 05/06/2019 04:01 PM/DISC: 05/06/2019 04:01 PM

http://www.businesswire.com/news/home/20190506005628/en